Learn More

BioPharmaceutical Emerging Best Practices Association (BEBPA)

We aim to foster publication of white papers and industry surveys which identify current practices, current technical hurdles and potential solutions relevant to the biopharmaceutical community – companies, regulators, clinicians. Identifying emerging issues early during development can often foster quicker and more efficient development for all firms.

Learn More

Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA), a non-profit organization managed by and for the benefit of the biopharmaceutical scientific community. BEBPA provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solutions thus facilitating safer and faster biopharmaceutical product development.

Smaller conferences will be held on various topics and a non-consensus white paper will be published delineating various approaches to solving these problems. The papers are not intended to be guidance documents, but rather strive to present the scientific community with a variety of approaches to potentially solve a common problem. Since the papers are not consensus documents, nor prescribe a preferred approach, publication can occur rapidly in open access journals and publicly available web pages and thus be part of the scientific discussion. Additionally, it is hoped that with the publication of potentially problem-solving approaches, the biopharmaceutical scientific community will accelerate the rate at which a future consensus best practice can be established.

"The comments regarding statistical analysis are very relevant to my daily work."
Stefan C., Statens Serum Institute
"Thank you for giving a niche training with affordable price."
Ammir S., Hikma, Pharmaceuticals Jordan
"Technically rejuvenating."
Nabeel H., Gulf Pharmaceutical Industries
"It was a wonderful collaborative and productive experience."
Patrick N., Janssen R&D LLC
"Lively and relevant discussions."
Harold T., Merz Pharmaceuticals
"A conference with perfect atmosphere for discussions!"
Mette O., Novo Nordisk A/S
"Interesting talks, great atmosphere, good discussion, nice people joining the conference."
Sonja K., Richter-Helm-Biologics
"It allows you to see what others in your field are doing. Without this meeting, it would be impossible for some of us to get this information."
Sheri K., Ligocyte Pharmaceuticals